GENE ONLINE|News &
Opinion
Blog

Deals
Trials & Approvals Hypercholesterolemia
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Partnerships NIH
Allen Institute Launches Next Phase of Mapping the Human Brain With $173 Million
2022-09-23
Partnerships Antibiotics
Spero Accepts GSK’s $66 Million to Save its Rejected Antibiotic
2022-09-23
Funding Theravance Biopharma
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Funding Cell and Gene Therapy
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Partnerships Oncology
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
Funding CDMO
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Funding Series D Funding
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Funding Mitochondrial DNA
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Funding Plaque Psoriasis
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
M&A Roche
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
Funding Antisense RNA
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
M&A Illumina
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
Partnerships Charles River Laboratories
Charles River Laboratories Partners With Non-Profit in an Effort to Cure a Rare Disease
2022-09-06
M&A Healthcare
CVS Beats Amazon in Signify Bidding War with $8 Billion Acquisition Offer
2022-09-06
1 … 12 13 14 15 16 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top